TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ACELLA

Infectious DiseaseCardiovascular
Generics

ACELLA is a generic drug manufacturer focused on Infectious Disease, Cardiovascular.

1974
Since
11
Drugs
-
Trials
140
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
LACOSAMIDE 2026-01-29
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
LACOSAMIDE 2026-01-21
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
DOXYCYCLINE HYCLATE 2025-12-09
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Cardiovascular 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Merck big-pharma
Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular
B BRAUN specialty
Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease